B&L contact lens marketing settlements have minimal effect on sales because pricing is unchanged.
This article was originally published in The Gray Sheet
Executive SummaryBAUSCH & LOMB/ATTORNEYS GENERAL PACT CODIFIES USE OF ONE TRADE NAME for three types of soft contact lenses previously marketed under different names. Under the terms of a $1.7 mil. settlement with the AGs of 17 states, Bausch & Lomb is required to continue its practice of marketing the three types of lenses under the same trade name. B&L changed to the one-name marketing approach in June.
You may also be interested in...
Civica Rx has won an investment of $55m through a deal with the Blue Cross Blue Shield Association of US health insurance firms to create a new subsidiary that will acquire and develop generic filings to be launched in the US from 2022.